Annual report pursuant to Section 13 and 15(d)

Cover Page

Cover Page - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Mar. 10, 2020
Jun. 30, 2019
Cover page.      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2019    
Document Transition Report false    
Entity File Number 001-37758    
Entity Registrant Name Moleculin Biotech, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 47-4671997    
Entity Address, Address Line One 5300 Memorial Drive    
Entity Address, Address Line Two Suite 950    
Entity Address, City or Town Houston    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 77007    
City Area Code 713    
Local Phone Number 300-5160    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol MBRX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Shell Company false    
Entity Public Float     $ 48
Entity Common Stock, Shares Outstanding   53,227,700  
Documents Incorporated by Reference Portions of this registrant’s definitive proxy statement for its 2020 Annual Meeting of Stockholders to be filed with the SEC no later than 120 days after the end of the registrant’s fiscal year are incorporated herein by reference in Part III of this Annual Report on Form 10-K.    
Entity Central Index Key 0001659617    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Amendment Flag false    
Current Fiscal Year End Date --12-31